Status:
COMPLETED
Polyphenol Enriched Extra-virgin Olive Oil and Postprandial Glycemia in Type 1 Diabetes (DOP)
Lead Sponsor:
Federico II University
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The aims of this study are to investigate the short term effects of MUFA alone vs. MUFA plus Polyphenols contained in the extra-virgin olive oil (EVOO) on the postprandial glycemic response in patient...
Detailed Description
In a recent study the use of extra virgin olive oil (EVOO) (rich in MUFA) to a high glycemic index meal attenuated the early PGR observed when this meal were consumed with either low-fat or butter (ri...
Eligibility Criteria
Inclusion
- Treatment with continuous subcutaneous insulin infusion for at least 6 months
- HbA1c less than 8.5% (69 mmol/mol)
Exclusion
- Pregnancy and breastfeeding
- Any other chronic or acute disease apart diabetes seriously affecting health status
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 20 2020
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04764786
Start Date
April 1 2019
End Date
November 20 2020
Last Update
February 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federico II University
Napoli, Naples, Italy, 80131